1558.HK लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 13:38):

Stats
आज की मात्रा	3.60M
औसत मात्रा	2.19M
बाजार मूल्य	11.14B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	5.19
ATR14	HKD0.0140 (0.11%)

मात्रा सहसंबंध

लंबा: -0.15 (neutral)

छोटा: -0.64 (weak negative)

Signal:(41.519) Neutral

YiChang HEC ChangJiang सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

YiChang HEC ChangJiang सहसंबंध - मुद्रा/वस्त्र

0.26
( neutral )

0.63
( weak )

0.00
( neutral )

-0.59
( weak negative )

0.54
( weak )

0.70
( moderate )

YiChang HEC ChangJiang वित्तीय

Annual	2023
राजस्व:	HKD6.29B
सकल लाभ:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
राजस्व:	HKD6.29B
सकल लाभ:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
राजस्व:	HKD3.74B
सकल लाभ:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
राजस्व:	HKD913.79M
सकल लाभ:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.39%) | Divividend Growth Potential Score: 4.12 - Potential for dividend initiation, but uncertain (17.56%)

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.12
Div. Directional Score	6.68	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3958.HK	Ex Dividend Junior	2023-05-23	Annually	0.00%
1773.HK	Ex Dividend Junior	2023-06-15	Annually	0.00%
0816.HK	No Dividend Player	2023-06-12	Insufficient data to determine frequency	0.00%
2359.HK	Ex Dividend Knight	2023-06-05	Annually	0.00%
1336.HK	Ex Dividend Junior	2023-07-06	Annually	0.00%
0386.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
6668.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
1890.HK	Ex Dividend Knight	2023-08-04	Annually	0.00%
0916.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
0038.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.505	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	0.443	1.000	3.13	3.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.641	1.000	7.55	7.55	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.16	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.505	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.894	2.00	9.37	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0783	1.500	-2.81	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.266	1.000	5.85	0	[0.1 - 0.5]
Total Score				4.12

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.